1177 Prospective Trial to Identify Optimal Bladder Cancer Surveillance Protocol: Reducing Costs While Maximizing Sensitivity

Karam, Jose A.; Shah, Jay; Kader, Karim; Svatek, Robert S.; Guo, Charles; Grossman, H. Barton; Munsell, Mark F.; Katz, Ruth; Dinney, Colin P.; Kamat, Ashish M.

doi:10.1016/j.juro.2010.02.677

Journal of Urology

2010

DOI: 10.1016/j.juro.2010.02.677

|View full text |Cite

1177 Prospective Trial to Identify Optimal Bladder Cancer Surveillance Protocol: Reducing Costs While Maximizing Sensitivity

Jose A. Karam¹,

Jay Shah²,

Karim Kader

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2010

2011

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Bladder Cancer: Current Management and Opportunities for a Personalized Approach

Galsky

Hall

2010

Mount Sinai J Medicine

View full text Add to dashboard Cite

Urothelial carcinoma of the bladder exists as a spectrum of clinical states ranging from non-muscle-invasive to muscle-invasive to advanced/metastatic disease. Each clinical state is associated with a unique tumor biology, prognosis, and approach to treatment. The field of personalized medicine offers the promise to individualize therapeutic decisions in each clinical state with the goal of preventing or delaying progression to more advanced disease states while optimizing quality of life. This review will discuss bladder cancer as a paradigm for the development of personalized cancer medicine, focusing on recent efforts, current challenges, and future opportunities.

show abstract

Bladder Cancer: Current Management and Opportunities for a Personalized Approach

Galsky

Hall

2010

Mount Sinai J Medicine

View full text Add to dashboard Cite

show abstract

Actualités concernant la prise en charge et le suivi des tumeurs vésicales n’infiltrant pas le muscle en 2010

Pignot

Irani²,

Bastide³

et al. 2011

Progrès en Urologie

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

1177 Prospective Trial to Identify Optimal Bladder Cancer Surveillance Protocol: Reducing Costs While Maximizing Sensitivity

Cited by 2 publications

References 0 publications

Bladder Cancer: Current Management and Opportunities for a Personalized Approach

Bladder Cancer: Current Management and Opportunities for a Personalized Approach

Actualités concernant la prise en charge et le suivi des tumeurs vésicales n’infiltrant pas le muscle en 2010

Contact Info

Product

Resources

About